Immune Checkpoint Inhibitor–Mediated Aseptic Meningitis and Hypophysitis
Immune Checkpoint Inhibitor–Mediated Aseptic Meningitis and Hypophysitis
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Immune checkpoint inhibitors have revolutionized cancer treatment, yet their use is associated with unique and sometimes unpredictable immune‐related adverse events. We present a case of a 67‐year‐old female with renal cell cancer treated with ipilimumab and nivolumab who developed aseptic meningitis and hypophysitis. This case highlights the chall...
Alternative Titles
Full title
Immune Checkpoint Inhibitor–Mediated Aseptic Meningitis and Hypophysitis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d35e035933d0444f902bf039fb904a62
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d35e035933d0444f902bf039fb904a62
Other Identifiers
ISSN
2090-6706
E-ISSN
2090-6714
DOI
10.1155/crom/3517328
